Treatment of Moderate to Severe Facial Acne Vulgaris

PHASE2CompletedINTERVENTIONAL
Enrollment

257

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

December 31, 2008

Conditions
Acne Vulgaris
Interventions
DRUG

Doxycycline 0.6 mg/kg/day

doxycycline 40 mg/day, oral, 12 weeks

DRUG

Doxycycline 1.2 mg/kg/day

doxycycline 80 mg/day, 12 weeks

DRUG

Doxycycline 2.4 mg/kg/day

doxycycline 160 mg/day, 12 weeks

DRUG

Placebo

Placebo, 12 weeks

Trial Locations (23)

14623

Warner Chilcott Investigational Site, Rochester

19008

Warner Chilcott Investigational Site, Broomall

19034

Warner Chilcott Investigational Site, Fort Washington

27103

Warner Chilcott Investigational Site, Winston-Salem

30078

Warner Chilcott Investigational Site, Snellville

30263

Warner Chilcott Investigational Site, Newnan

33175

Warner Chilcott Investigational Site, Miami

40217

Warner Chilcott Investigational Site, Louisville

45219

Warner Chilcott Investigational Site, Cincinnati

48038

Warner Chilcott Investigational Site, Clinton Township

75246

Warner Chilcott Investigational Site, Dallas

77056

Warner Chilcott Investigational Site, Houston

77845

Warner Chilcott Investigational Site, College Station

78229

Warner Chilcott Investigational Site, San Antonio

78759

Warner Chilcott Investigational Site, Austin

80210

Warner Chilcott Investigational Site, Denver

90045

Warner Chilcott Investigational Site, Los Angeles

91436

Warner Chilcott Investigational Site, Encino

94538

Warner Chilcott Investigational Site, Fremont

95816

Warner Chilcott Investigational Site, Sacramento

97210

Warner Chilcott Investigational Site, Portland

99204

Warner Chilcott Investigational Site, Spokane

87106-5239

Warner Chilcott Investigational Site, Albuquerque

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Warner Chilcott

INDUSTRY

NCT00612573 - Treatment of Moderate to Severe Facial Acne Vulgaris | Biotech Hunter | Biotech Hunter